An evidence-based systematic review of gymnema (Gymnema sylvestre R. Br.) by the Natural Standard Research Collaboration
Ulbricht C, Abrams TR, Basch E, Davies-Heerema T, Foppa I, Hammerness P
Published in Journal of Dietary Supplements
Methodology
Evidence-graded systematic review of clinical literature, pharmacology, interactions, adverse effects and dosing for gymnema
Key Findings
Evidence for blood-glucose lowering in type 1 and type 2 diabetes was graded as limited and preliminary; hypoglycaemia risk exists when combined with diabetes drugs.
Conclusions
Gymnema evidence is preliminary and its main practical concern is additive hypoglycaemia with medication.
Limitations
Older evidence base; grading is qualitative.
Supplements Studied
Hypoglycaemia risk exists when gymnema is combined with diabetes drugs.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.